Articles On Micro-X (ASX:MX1)
Title | Source | Codes | Date |
---|---|---|---|
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device
Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past... |
Stockhead | MX1 | 1 year ago |
ScoPo’s Powerplays: ASX health stocks fall as Mach7 lands its biggest customer yet
The ASX Health sector has fallen ~1.5% in its first trading week of 2023 Mach7 has surged after landing its largest ever customer contract Proteomics gets US approval for PromarkerD test for diabetic kidney disease Healthcare and life sc... |
Stockhead | MX1 | 1 year ago |
The A to Z of Dr Boreham’s Crucible in 2022
The long and short of 2022 is that it was a frustrating period for the Australian biotech sector but one with its fair share of rewards as the sector’s exponents furthered worthy drugs, diagnostics, devices and doodahs. For the sixth year,... |
Stockhead | MX1 | 1 year ago |
How out of favour Biotech has a PR problem and could learn from Dr Karl
ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and... |
Stockhead | MX1 | 1 year ago |
ASX Quarterlies: These tech and health stocks finished the quarter with a bang
It’s quarterlies season again as the ASX market announcements page becomes increasingly flooded with earnings lodgements. To save you the trouble of trudging through it all, we’ve wrapped up the highlights from some of the reports that caug... |
Stockhead | MX1 | 1 year ago |
Webinar Recap – EZZ, ELS, MX1 & QXR
ShareCafeWebinar Recap – EZZ, ELS, MX1 & QXR Catch up on the full webinar presentations from EZZ Life Sciences (ASX: EZZ), Elsight (ASX: ELS), Micro-X (ASX: MX1) & QX Resources (ASX: QXR) Webinar Recap – EZZ, ELS, MX1 & QXRComp... |
ShareCafe | MX1 | 1 year ago |
Micro-X (ASX: MX1) – Webinar Presentation
ShareCafeMicro-X (ASX: MX1) – Webinar Presentation Peter Rowland – Managing Director – Mirco-X is a leading global revolution company in medical and security imaging products, which designs, develops, and manufactures ultra-lightweight car... |
ShareCafe | MX1 | 1 year ago |
Market Highlights: ASX poised for another bleak day, and 5 ASX small caps to watch on Monday
The ASX will open more than 1% lower on Monday Wall Street tumbled again on Friday on recession fears UK announced historic tax cuts Local shares are set to open much lower on Monday. At 8am AEST, the ASX 200 October futures contract is p... |
Stockhead | MX1 | 1 year ago |
Evening Report: 19 September, 2022
ShareCafeEvening Report: 19 September, 2022 by Paul Sanger At the closing bell, the S&P/ASX 200 was 0.28 per cent or 19.20 points lower at 6719.90. Futures The Dow Jones futures are pointing to a fall of 118 points. The S&P 500 fu... |
ShareCafe | MX1 | 1 year ago |
Guess which ASX medical tech share soared 37% at one point today
The Micro-X Ltd (ASX: MX1) share price exploded today on news of a $15 million investment. Micro-X shares surged 37% from 13.5 cents to 18.5 cents before retreating. The company’s shares finished the day up 26%. Let’s take a look at what... |
Motley Fool | MX1 | 1 year ago |
Closing Bell: Iffy ASX 200 fizzles, AIC Mines plays master of puppets with takeover target Demetallica
The ASX 200 is vacillating Small caps are down over 1.3% Demetallica is a great name and it’s up 40% on takeover talk The benchmark ASX 200 is flat as on Monday. The ASX Emerging Companies (XEC) index has lost 1.3%. REITs and Gold are h... |
Stockhead | MX1 | 1 year ago |
Lunch Report: 19 September, 2022
ShareCafeLunch Report: 19 September, 2022 by Paul Sanger At noon, the S&P/ASX 200 is 0.10 per cent or 7.00 points higher at 6746.10. The SPI futures are pointing to a rise of 5 points. Best and worst performers The best-performing sec... |
ShareCafe | MX1 | 1 year ago |
Stocks of the Hour: 19 September, 2022
ShareCafeStocks of the Hour: 19 September, 2022 Australian hi-tech company Micro-X Ltd (ASX:MX1) a leader in x-ray technology for health and security markets globally, is pleased to announce a strategic collaboratio... |
ShareCafe | MX1 | 1 year ago |
Stocks of the Hour: Micro-X, IVE Group, Origin Energy
19 Sep 2022 - A snapshot of the stocks on the move featuring Micro-X (ASX:MX1), IVE Group (ASX:IGL) and Origin Energy (ASX:ORG). |
FNN | MX1 | 1 year ago |
Closing Bell: Local markets go ex-div and surrender; Peppermint Innovation jumps 41% and a Newtowner on me for anyone who can explain why
ASX 200 sinks 2% Small caps get crushed, down 2.5% Region, AUD and miners sink on weaker China activity The local market is being dragged to hell by mining, materials and gold stocks, which are down between 4% and 5%. The S&P/ASX... |
Stockhead | MX1 | 1 year ago |
ASX Tech Stocks: Giant US drone to test hypersonic missiles; DroneShield nabs $2m EU order
The RangeHawk drone has a whopping 40m wingspan and is set to test hypersonic weapons DroneShield secures $2m contract from European Government customer for its counterdrone tech Aerospace player Quickstep has had to expand its Geelong f... |
Stockhead | MX1 | 1 year ago |
FNArena Corporate Results Monitor – 31-08-2022
Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AMS)) - Atomos ((ATA)) - Atturra ((BST)) - Best & Less ((BTH)) - Bigtincan Holdings ((BBT)) - BlueBet Holdings ((BVS)) - Bravura Solutions ((BUB)) - Bubs Australia (... |
FNArena | MX1 | 1 year ago |
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs
US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F... |
Stockhead | MX1 | 1 year ago |
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit
A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m... |
Stockhead | MX1 | 1 year ago |
Bargain buys or just busted? Here are the 10 biggest tech losers in the June sell-off
114 tech stocks were trading down for the month of June 11 stocks flatlined and only 22 were in the green The biggest losers were iSYNERGY, Icetana and Eroad Wowzers. Even by tech stocks standards, June was a bit of a shocker, with the... |
Stockhead | MX1 | 1 year ago |
Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX
Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech... |
Stockhead | MX1 | 1 year ago |
Top 10 at 10: The ASX stocks investors like (and dislike) the most in early trade Tuesday
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | MX1 | 1 year ago |
ASX Tech Stocks: Google engineer says AI chatbot is sentient and Xtek wraps up $9.5m ballistics order
Google engineer reckons chatbot has become sentient Xtek sends $9.5m of specialist ballistic products to secret US customer Micro-X nabs new US distributor for its mobile Rover x-ray product Google engineer Blake Lemoine has been sent o... |
Stockhead | MX1 | 1 year ago |
ScoPo’s Powerplays: Who else needs help remembering the good times of ASX health stocks?
Dark clouds continue to hover over ASX health stocks Health imaging company Volpara’s FY22 results in line with expectations Fight for fertility company Virtus enters another round Healthcare and life sciences expert Scott Power – a senio... |
Stockhead | MX1 | 1 year ago |
CONCEPT DESIGN MILESTONE FOR DHS SELF-SCREEN CHECKPOINT STATION ACHIEVED
Successful first stage design milestone for Micro-X Passenger Self screening station – Unlocks $0.7m second phase of work ADELAIDE, Australia and SEATTLE, May 24, 2022 /PRNewswire/ — Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X... |
FNArena | MX1 | 1 year ago |
ScoPo’s Powerplays: Health stocks on a wave of jitters as inflation storm gathers
Healthcare and life sciences expert Scott Power – a senior analyst with Morgans Financial for 24 years – on what the movers and shakers have been doing in health and which ASX health stocks make Scott’s Powerplays. Look in the mirror and li... |
Stockhead | MX1 | 1 year ago |
Check Up: Money managers are still bullish on Healthcare; here’s what they said
The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week Dr Anthony Faucci, America’s top infectious disea... |
Stockhead | MX1 | 2 years ago |
Closing Bell: ASX surrenders early gains, while honest small caps crash and burn from the open
ASX gives back early gains on Wednesday Small caps whacked as Fed Hawks get hawky, bonds get toppy, coal prices surge, oil prices plunge… again And now the market news in briefs. Unlike the no-frills, straight-shooting ASX Emerging Compan... |
Stockhead | MX1 | 2 years ago |
Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly
The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot... |
Stockhead | MX1 | 2 years ago |
Webinar Recap – MX1, SPL, MAP, RFL & RAP
ShareCafeWebinar Recap – MX1, SPL, MAP, RFL & RAP Catch up on the full webinar with presentations from Micro-X (ASX: MX1), Starpharma (ASX: SPL), Microba Life Sciences (ASX: MAP), RLF AgTech (ASX: RFL) & ResApp (ASX: RAP) Webinar R... |
ShareCafe | MX1 | 2 years ago |
Micro-X (ASX: MX1) – Webinar Presentation
ShareCafeMicro-X (ASX: MX1) – Webinar Presentation Peter Rowland – MD – Micro-X Limited designs, develops, and manufactures ultra-lightweight carbon X-ray products for healthcare. Micro-X (ASX: MX1) – Webinar PresentationCompany News |
ShareCafe | MX1 | 2 years ago |
ScoPo’s Powerplays: Which ASX health stocks are winners from the Federal Budget?
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in ASX health stocks. Good news for coffee lovers, particularly those w... |
Stockhead | MX1 | 2 years ago |
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?
Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve... |
Stockhead | MX1 | 2 years ago |
Closing Bell: Any price is totally right
The ASX Emerging Companies Index (XEC) has ended 1.5% higher on Wednesday, driven by a new EV car as a few battery metal small caps locked in the right prices from a government ready to pay. The ASX200 has also risen a further 1.1% driven b... |
Stockhead | MX1 | 2 years ago |
Check Up: The future of telehealth, and the best and worst performing ASX health stocks for the month
Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal... |
Stockhead | MX1 | 2 years ago |
Top 10 at 10: These ASX stocks are cruising along nicely today
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | MX1 | 2 years ago |
Check Up: Johnson & Johnson manoeuvre causes a stir, as CSL pulls Healthcare higher on the ASX
The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby... |
Stockhead | MX1 | 2 years ago |
SocPo’s Powerplays: Who’s making a gritty comeback?
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Everyone loves a comeback. Just... |
Stockhead | MX1 | 2 years ago |
SocPo’s Powerplays: A few healthcare gems among the carnage
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. During his Australian Open quar... |
Stockhead | MX1 | 2 years ago |
Check Up: As Omicron rages, rapid antigen testing specialist Atomo surges nearly 50pc
At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform... |
Stockhead | MX1 | 2 years ago |
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining. Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %... |
Stockhead | MX1 | 2 years ago |
Check Up: Neuren close to FDA drug approval and Compumedics fires up Aussie factory for medical wearables
It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining. Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont... |
Stockhead | MX1 | 2 years ago |
ScoPo’s Powerplays: Christmas rally runs out of puff, but market awaits crucial release from Neuren
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week At the time... |
Stockhead | MX1 | 2 years ago |
Check Up: Sustainable Nutrition riding high and Singular Health branches out from… health
It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining. Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M... |
Stockhead | MX1 | 2 years ago |
ScoPo’s Powerplays: AGM season ‘flushes out negative surprises’ but creates buying opportunities
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week The AGM sea... |
Stockhead | MX1 | 2 years ago |
ASX Tech Stocks: Linius edges higher with new exec appointments while UBI nabs a US distribution deal
Linius pursues commercialisation of video virtualisation engine tech UBI up after nabbing new distribution deal for its Sentia wine product Keypath unchanged 40.8% revenue increase to US$30.4 million Linius Technologies (ASX:LNU) Cloud... |
Stockhead | MX1 | 2 years ago |
ScoPo’s Powerplays: ‘Market volatility could lead to a rally by Christmas’
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week At the time... |
Stockhead | MX1 | 2 years ago |
Top brokers name 3 ASX small cap shares to buy
As well as covering large caps, many brokers also cover smaller companies. In light of this, I thought I would scour through a range of recent notes to see which small cap ASX shares are in favour with brokers at present. Three that have b... |
Motley Fool | MX1 | 2 years ago |
Closing Bell: Afterpay-backed Touch Ventures makes a strong debut while the ASX floats in a sea of red
Local stocks closed in the red on Wednesday (as expected), after US stocks posted their biggest fall since June overnight. The ASX 200 threatened to tank early but gained back some ground in afternoon trade to finish 1.08% lower. By sector,... |
Stockhead | MX1 | 2 years ago |
Closing Bell: ASX has best day in nearly 2 months
The ASX 200 closed 1% higher at 7,370 points, a level that saw it nearly recoup losses made earlier this week. The ASX Emerging Companies Index rose 1.64% to close at 2,554 points. All sectors were in the green with the biggest winners bein... |
Stockhead | MX1 | 2 years ago |